Clopidogrel Taw Pharma (previously Clopidogrel Mylan) Europska Unija - hrvatski - EMA (European Medicines Agency)

clopidogrel taw pharma (previously clopidogrel mylan)

taw pharma (ireland) limited - klopidogrel hidroklorid - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombotska sredstva - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:,    - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). ,     - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event.  , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.

Clopidogrel Viatris (previously Clopidogrel Taw Pharma) Europska Unija - hrvatski - EMA (European Medicines Agency)

clopidogrel viatris (previously clopidogrel taw pharma)

viatris limited - klopidogrel besilat - peripheral vascular diseases; stroke; myocardial infarction - antitrombotska sredstva - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). porastom segmenta st akutni infarkt miokarda, u kombinaciji s ask u liječenju pacijenata koji imaju pravo na thrombolytic terapije. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. za više informacija, molimo pogledajte odjeljak 5.

INTRA DYSOVINOL Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

intra dysovinol

intracare b.v., voltaweg 4, 5466 az veghel, nizozemska - dinatrijev cink edta - otopina za uporabu u vodi za piće - probavni sustav i mijena tvari, antidijaroici, crijevni antiinfekcijski i protuupalni lijekovi - svinja (tovnih svinja)

NEOSITOL 10% Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

neositol 10%

propharma vet d.o.o., osijek, hrvatska - levamizol - prašak za peroralnu primjenu - govedo, ovca, svinja

Ropivakain BioQ Pharma 2 mg/ml otopina za infuziju u sustavu za primjenu Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

ropivakain bioq pharma 2 mg/ml otopina za infuziju u sustavu za primjenu

bioq pharma b.v., prins bernhardplein 200, amsterdam, nizozemska - ropivakainklorid hidrat - otopina za infuziju u sustavu za primjenu - 2 mg/ml - urbroj: 1 ml otopine za infuziju sadrži ropivakainklorid hidrat što odgovara 2 mg ropivakainklorida

Nurofen 200 mg ljekoviti flaster Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

nurofen 200 mg ljekoviti flaster

reckitt benckiser d.o.o., ulica grada vukovara 269d, zagreb, hrvatska - ibuprofen - ljekoviti flaster - 200 mg - urbroj: svaki ljekoviti flaster sadrži 200 mg ibuprofena

BAYCOX BOVIS Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

baycox bovis

bayer d.o.o., radnička cesta 80, 10000 zagreb, hrvatska - toltrazuril - peroralna suspenzija - antiparazitik - goveda (telad na farmama mliječnih krava)

CEVAC TRANSMUNE Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

cevac transmune

ceva santé animale, 10 av. de la ballastière, 33500 libourne, francuska - atenuirani virus gumborske bolesti, soj winterfield 2512 - liofilizat za suspenziju za injekciju - imunološki vmp - kokoši

ECTOBAND Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

ectoband

vitakraft hobby program d.o.o., klanjec 4, hrvatski leskovac - diazinon - antiparazitski ovratnik za mačke - antiparazitik - mačaka